# PROMISS: Simvastatin Prevents the Contrast Induced Acute Renal Failure in Patients With Renal Insufficiency Undergoing Coronary Angiography

> **NCT00259441** · PHASE4 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 320 (—)

## Conditions studied

- Kidney Failure

## Interventions

- **DRUG:** Simvastatin

## Key facts

- **NCT ID:** NCT00259441
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** —
- **Final completion:** 2006-03
- **Target enrollment:** 320 (—)
- **Last updated:** 2007-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00259441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00259441, "PROMISS: Simvastatin Prevents the Contrast Induced Acute Renal Failure in Patients With Renal Insufficiency Undergoing Coronary Angiography". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00259441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*